Funder: CURE Childhood Cancer
Due Dates (Anticipated): February 2027 (LOI) | March 2027 (Full application)
Funding Amounts: T2C: up to $330,000 over 2 years | Early Investigator: up to $220,000 over 2 years
Summary: Supports targeted childhood cancer research to improve survival while preserving children’s long-term health and quality of life.
Key Information: Applicants must be full-time faculty at a US-based nonprofit research institution; full proposals are by invitation.
Description
CURE Childhood Cancer funds targeted research aimed at conquering childhood cancer without sacrificing survivors’ future health and quality of life. Its research program offers two awards: Translation to Clinic (T2C), for investigators from Assistant to Full Professor, and Early Investigator (EI), for beginning scientists and physician-scientists. CURE prioritizes research addressing recurrent or hard-to-treat cancers for which no effective treatment exists, particularly work likely to have a therapeutic impact within two to three years.
Proposals are assessed for scientific merit and alignment with CURE’s research goals. An independent Peer Review Committee reviews and scores applications and recommends projects to the Board of Directors, which makes final funding decisions based on scores and available funds.
